Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed.
PulmonaromFrontiers in cellular and infection microbiology · 2026
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Juan A Hernández-AcevesDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Cto. Escolar, C.U., Coyoacán, Mexico City 04510, Mexico.ORCID 0000-0002-6451-8832
Sandra Georgina Solano-GálvezUnidad de Investigación UNAM-INC, División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Arturo A Wilkins-RodríguezUnidad de Investigación UNAM-INC, División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
José Delgado-DomínguezLaboratorio de Inmunoparasitología, Unidad de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.ORCID 0000-0003-3570-3331
Alberto Garcia LozanoLaboratorio de Inmunobiología, Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Cto. Escolar S/N, C.U., Coyoacán, Mexico City 04510, Mexico.ORCID 0009-0007-9978-4448
Carlos Cabello-GutierrezDepartamento de Investigación en Virología y Micología, Instituto Nacional de Enfermedades Respiratorias (INER), Calzada de Tlalpan 4502 Belisario Domínguez Tlalpan, Mexico City 14080, Mexico.ORCID 0000-0002-3192-8915
Lidia Flor Estela HuertaLaboratorio de Farmacología, Escuela Militar de Graduados en Sanidad, Universidad del Ejército y Fuerza Aérea, Secretaría de la Defensa Nacional, Mexico City 11200, Mexico.
Gladis FragosoDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Cto. Escolar, C.U., Coyoacán, Mexico City 04510, Mexico.ORCID 0000-0003-3885-1858
Laila Gutiérrez-KobehUnidad de Investigación UNAM-INC, División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0002-4414-6437
Rosalino Vázquez-LópezLaboratorio de Farmacología, Escuela Militar de Graduados en Sanidad, Universidad del Ejército y Fuerza Aérea, Secretaría de la Defensa Nacional, Mexico City 11200, Mexico.ORCID 0000-0002-1982-7329
Funding
Opella, Sanofi Consumer Healthcare business unit 18/08/2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Immunomodulatory Effects of Pulmonarom · full record | Socratic